...
首页> 外文期刊>Dysphagia >A Comparative Study Between Modified Starch and Xanthan Gum Thickeners in Post-Stroke Oropharyngeal Dysphagia
【24h】

A Comparative Study Between Modified Starch and Xanthan Gum Thickeners in Post-Stroke Oropharyngeal Dysphagia

机译:脑卒中后吞咽困难的淀粉和黄原胶增稠剂的比较研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Thickeners are used in post-stroke oropharyngeal dysphagia (OD) as a compensatory therapeutic strategy against aspirations. To compare the therapeutic effects of modified starch (MS) and xanthan gum (XG) thickeners on swallow safety and efficacy in chronic post-stroke OD patients using clinical and videofluoroscopic (VFS) assessment. Patients were studied by clinical assessment (volume-viscosity swallow test, V-VST) and VFS using 3 volumes (5, 10, 20 mL) and 3 viscosities (liquid, nectar and spoon thick), comparing MS and XG. We studied 122 patients (46MS, 76XG). (A) V-VST showed that both thickeners similarly improved safety of swallow. Prevalence of safe swallowing significantly increased with enhanced viscosity (P < 0.001 vs liquid), MS: 47.83 % at liquid, 84.93 % at nectar and 92.96 % at spoon thick; XG: 55.31 % at liquid, 77.78 % at nectar and 97.84 % at spoon thick. Patients on MS reported higher prevalence of pharyngeal residue at spoon-thick viscosities. (B) VFS: increasing bolus viscosity with either thickener increased prevalence of safe swallows (P < 0.001 vs liquid), MS: 30.25 % liquid, 61.07 % nectar and 92.64 % spoon thick; XG: 29.12 % liquid, 71.30 % nectar and 89.91 % spoon thick. Penetration-aspiration scale score was significantly reduced with increased viscosity with both thickeners. MS increased oral and pharyngeal residues at nectar and spoon-thick viscosities but XG did not. Timing of airway protection mechanisms and bolus velocity were not affected by either thickener. Increasing bolus viscosity with MS and XG thickeners strongly and similarly improved safety of swallow in chronic post-stroke OD by a compensatory mechanism; in contrast only MS thickeners increased oropharyngeal residue.
机译:增稠剂可用于中风后口咽性吞咽困难(OD),作为对抗误吸的补偿性治疗策略。使用临床和视频透视(VFS)评估,比较改性淀粉(MS)和黄原胶(XG)增稠剂对慢性卒中后OD患者吞咽安全性和功效的治疗效果。通过临床评估(体积-粘度吞咽试验,V-VST)和VFS,使用3份体积(5、10、20 mL)和3份粘度(液体,花蜜和汤匙浓稠度)对患者进行了研究,比较了MS和XG。我们研究了122例患者(46MS,76XG)。 (A)V-VST表明,两种增稠剂均相似地提高了吞咽的安全性。随着粘度的增加,安全吞咽的发生率显着增加(相对于液体,P <0.001),MS:液体时为47.83%,花蜜为84.93%,汤匙浓稠时为92.96%。 XG:在液体中为55.31%,在花蜜中为77.78%,在汤匙厚时为97.84%。接受MS治疗的患者报告说,汤匙浓稠的咽部残留率更高。 (B)VFS:使用任一种增稠剂增加药丸粘度,增加安全吞咽的发生率(相对于液体,P <0.001),MS:30.25%的液体,61.07%的花蜜和92.64%的汤匙稠度; XG:29.12%液体,71.30%花蜜和89.91%汤匙稠。随着两种增稠剂粘度的增加,渗透-吸入量表评分显着降低。 MS增加了花蜜和浓汤粘度时的口腔和咽部残留,而XG没有。两种增稠剂均不影响气道保护机制的时机和推注速度。 MS和XG增稠剂可增加推注粘度,并通过补偿机制同样有效地提高了慢性卒中后OD吞咽的安全性;相反,只有MS增稠剂会增加口咽残留。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号